WANG Juan, GE Fanghong, CAO Jianfeng, HE Yunhua, SHAN Guiqin. Efficacy of nanoparticle albumin-bound paclitaxel combined with platinum drugs in treatment of head and neck tumors and its influence on activity of natural killer cells[J]. Journal of Clinical Medicine in Practice, 2021, 25(20): 52-55. DOI: 10.7619/jcmp.20213209
Citation: WANG Juan, GE Fanghong, CAO Jianfeng, HE Yunhua, SHAN Guiqin. Efficacy of nanoparticle albumin-bound paclitaxel combined with platinum drugs in treatment of head and neck tumors and its influence on activity of natural killer cells[J]. Journal of Clinical Medicine in Practice, 2021, 25(20): 52-55. DOI: 10.7619/jcmp.20213209

Efficacy of nanoparticle albumin-bound paclitaxel combined with platinum drugs in treatment of head and neck tumors and its influence on activity of natural killer cells

More Information
  • Received Date: August 08, 2021
  • Available Online: October 11, 2021
  • Published Date: October 27, 2021
  •   Objective  To explore the efficacy of nanoparticle albumin-bound paclitaxel (nab-PTX) combined with platinum drugs in the treatment of head and neck tumors and its influence on the activity of natural killer (NK) cells.
      Methods  Totally 75 patients with head and neck tumors were randomly divided into two groups. Control group (n=38) was treated with paclitaxel (PTX) and platinum drugs, while observation group (n=37) was treated with nab-PTX and platinum drugs. The disease control rate (DCR), activity of NK cells as well as toxic and side effects were compared between the two groups at different time points. After a year of follow up, the survival rate of the two groups was compared.
      Results  The DCR of the observation group in 1 cycle, 2 and 4 cycles after treatment was significantly higher than that of the control group (P < 0.05). The incidence rates of toxic and side effects such as peripheral neuritis, diarrhea, nausea and vomiting, leucopenia and thrombocytopenia in the observation group were significantly lower than that in the control group (P < 0.05). The activity of NK cells in the observation group was significantly higher than that in the control group at 2 and 4 cycles after treatment (P < 0.05). After a year of follow-up, the survival rate of the observation group was significantly higher than that of the control group, and the survival time was significantly longer than that of the control group (P < 0.05 or P < 0.01).
      Conclusion  The efficacy of nab-PTX combined with platinum drugs therapy is significant in patients with head and neck tumors, which can prolong the survival time, improve the activity of NK cells and reduce the incidence of adverse reactions.
  • [1]
    郑璐, 胡静, 许权, 等. 紫杉醇、紫杉醇脂质体和白蛋白结合型紫杉醇在头颈肿瘤中的疗效比较[J]. 中国现代应用药学, 2019, 36(11): 1391-1394. https://www.cnki.com.cn/Article/CJFDTOTAL-XDYD201911016.htm
    [2]
    王蓓蓓, 李玉芝, 王丽华, 等. 紫杉醇或多西他赛联合奈达铂在宫颈癌新辅助化疗中的疗效及安全性[J]. 蚌埠医学院学报, 2017, 42(7): 864-867. https://www.cnki.com.cn/Article/CJFDTOTAL-BANG201707008.htm
    [3]
    李楠, 孙亚楠, 杨亮, 等. 紫杉醇腹腔热灌注治疗晚期卵巢癌临床观察[J]. 河北医科大学学报, 2017, 38(12): 1409-1412. doi: 10.3969/j.issn.1007-3205.2017.12.012
    [4]
    葛琳. 紫杉醇脂质体联合贝伐珠单抗治疗中晚期胃癌的疗效及其对免疫功能的影响[J]. 中国基层医药, 2018, 25(11): 1387-1390. doi: 10.3760/cma.j.issn.1008-6706.2018.11.008
    [5]
    刘寿贵, 林舜国. 白蛋白结合型紫杉醇治疗紫杉类耐药转移性乳腺癌47例[J]. 肿瘤学杂志, 2018, 24(7): 692-695. doi: 10.3760/cma.j.issn.1004-4221.2018.07.015
    [6]
    雷大鹏, 刘大昱, 马小洁, 等. 2015年中华医学会杂志社指南与进展巡讲头颈外科专业(青岛站)暨全国头颈肿瘤手术治疗专题学术会议纪要[J]. 中华耳鼻咽喉头颈外科杂志, 2015, 50(10): 865-866. doi: 10.3760/cma.j.issn.1673-0860.2015.10.018
    [7]
    GOYAL S, OAK E, LUO J, et al. Minimal activity of nanoparticle albumin-bound (nab) paclitaxel in relapsed or refractory lymphomas: results of a phase-I study[J]. Leuk Lymphoma, 2018, 59(1/2): 357-362.
    [8]
    肖鑫, 彭万仁, 汪超. 紫杉醇脂质体联合卡铂与紫杉醇联合卡铂治疗头颈部肿瘤的临床疗效[J]. 中国肿瘤临床与康复, 2017, 24(6): 689-691. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZK201706014.htm
    [9]
    房伟, 马云涛, 马世勋, 等. 复方苦参注射液联合紫杉醇和替吉奥治疗晚期胃癌的临床疗效观察[J]. 西部中医药, 2021, 34(4): 100-104. https://www.cnki.com.cn/Article/CJFDTOTAL-GSZY202104025.htm
    [10]
    张志安, 易红艳. 紫杉醇联合铂类新辅助化疗局部晚期宫颈癌效果及对Smac、Survivin、MMP-2表达的影响[J]. 河北医学, 2018, 24(3): 385-389. doi: 10.3969/j.issn.1006-6233.2018.03.009
    [11]
    刘寿贵, 林舜国. 白蛋白结合型紫杉醇治疗紫杉类耐药转移性乳腺癌47例[J]. 肿瘤学杂志, 2018, 24(7): 692-695. doi: 10.3760/cma.j.issn.1004-4221.2018.07.015
    [12]
    QIN S, YU H, WU X, et al. Weekly albumin-bound paclitaxel/cisplatin versus gemcitabine/cisplatin as first-line therapy for patients with advanced non-small-cell lung cancer: A phase Ⅱ open-label clinical study[J]. Chin J Cancer Res, 2019, 31(2): 339-348. doi: 10.21147/j.issn.1000-9604.2019.02.08
    [13]
    何芳, 王红梅, 贾保昌, 等. 白蛋白结合型紫杉醇在局部晚期/晚期头颈部肿瘤治疗中的研究进展及展望[J]. 中国肿瘤临床, 2019, 46(20): 1061-1066. doi: 10.3969/j.issn.1000-8179.2019.20.185
    [14]
    李文文, 韩磊, 张志国, 等. 白蛋白结合型紫杉醇治疗晚期难治性恶性肿瘤的疗效及安全性[J]. 中国医师杂志, 2019, 21(12): 1803-1807. doi: 10.3760/cma.j.issn.1008-1372.2019.12.012
    [15]
    HU Z, ZHENG B, XU J, et al. An albumin-bound drug conjugate of paclitaxel and indoleamine-2, 3-dioxygenase inhibitor for enhanced cancer chemo-immunotherapy[J]. Nanotechnology, 2020, 31(29): 295101. doi: 10.1088/1361-6528/ab824d
    [16]
    刘萍萍, 李敏, 笪洁. 白蛋白结合型紫杉醇作为三线及以上方案治疗晚期恶性肿瘤的临床观察[J]. 安徽医药, 2016, 20(8): 1565-1567. doi: 10.3969/j.issn.1009-6469.2016.08.041
    [17]
    鲁翰林, 宋盈莹, 申春苹, 等. 紫杉醇对IL-36γ介导的抗肿瘤作用的影响[J]. 江苏大学学报: 医学版, 2018, 28(5): 381-385. https://www.cnki.com.cn/Article/CJFDTOTAL-ZJYZ201805003.htm
  • Related Articles

    [1]GU Xin, JING Liwei, WANG Andi, LIU Jun, DAI Yongqiang, ZHANG Baoling. Analysis of the recurrence rate and risk factors of renal calculi after intracavitary lithotripsy[J]. Journal of Clinical Medicine in Practice, 2024, 28(10): 39-41. DOI: 10.7619/jcmp.20232864
    [2]YANG Xingfei, LI Shanshan, LI Zhuo. Effects of single-port laparoscopic extraperitoneal ligation on surgical indexes, intestinal mucosal barrier function and recurrence rate in children with pediatric inguinal hernia[J]. Journal of Clinical Medicine in Practice, 2024, 28(7): 75-78. DOI: 10.7619/jcmp.20234152
    [3]LIU Xiaohong, LI Mei, WANG Fengyun, SI Yuchen, DU Xiaoli, SHI Liangliang, SHAO Haiou, CHEN Li, ZHANG Hongyan. Effect of modified Qiankun Yudan Decoction combined with leuprorelin acetate on serum carbohydrate antigen 125 and recurrence rate in patients with adenomyosis[J]. Journal of Clinical Medicine in Practice, 2023, 27(18): 133-137. DOI: 10.7619/jcmp.20231988
    [4]WANG Buyun, LEI Lei. Effect of tension-free herniorrhaphy in treating inguinal hernia in the elderly patients[J]. Journal of Clinical Medicine in Practice, 2020, 24(8): 104-106. DOI: 10.7619/jcmp.202008028
    [5]LIU Yi, WANG Guanglei. Effect of Beifuji combined with Rehabilitation Fluid on recurrent oral ulcer and its influence on inflammatory factors and recurrence rate[J]. Journal of Clinical Medicine in Practice, 2019, (4): 90-92,95. DOI: 10.7619/jcmp.201904027
    [6]CHEN Xiaohong, HUANG Xia. Effect of comprehensive nursing intervention on the compliance behavior and recurrence rate of patients with lumbar disc herniation[J]. Journal of Clinical Medicine in Practice, 2017, (12): 70-72. DOI: 10.7619/jcmp.201712021
    [7]LI Shuiyan, LUO Dejun. Effect of reason-targeted nursing on health behavior and recurrence rate of patients with peptic ulcer[J]. Journal of Clinical Medicine in Practice, 2016, (8): 50-52. DOI: 10.7619/jcmp.201608016
    [8]DONG Shuling, DONG Lingzhi, REN Zhiyan. Influence of nursing intervention on reduction of incidence rate of complications in hypertension patients[J]. Journal of Clinical Medicine in Practice, 2013, (20): 18-20. DOI: 10.7619/jcmp.201320006
    [9]XU Zhuowen, ZHENG Ruolong, LI Weizhang, CHEN Jianbo, QIAN Huidong, CHEN Xinjun. Impact of obstructive sleep apnea syndrome on the recurrent rate of patients with atrial fibrillation after radiofrequency ablation[J]. Journal of Clinical Medicine in Practice, 2013, (9): 23-25. DOI: 10.7619/jcmp.201309007
    [10]YANG Yan. Influence of comprehensive nursing intervention on compliance of medication and recurrence rate in discharged patients with schizophrenia[J]. Journal of Clinical Medicine in Practice, 2013, (8): 55-57. DOI: 10.7619/jcmp.201308021
  • Cited by

    Periodical cited type(5)

    1. 王燕,汪晶晶,王红丽,孔羽. 急性脑梗死并认知功能障碍的血清生化指标预测研究. 黑龙江医学. 2025(06): 659-662 .
    2. 栗昭生,那丽莎,关亚新,张忠敏. 孤立性丘脑梗死后发生认知障碍的影响因素分析. 中国当代医药. 2024(14): 29-32 .
    3. 叶双双,齐智慧. 灯盏生脉胶囊对脑梗死认知障碍的影响. 光明中医. 2024(13): 2626-2629 .
    4. 燕炼钢,周婷,贾泽坤,杨娅,江娜,何彦蓉,王储蓄,殷红彪. 针刺阳明经配合补阳还五汤加减治疗气虚血瘀型脑梗死的效果分析. 实用临床医药杂志. 2023(22): 105-109 . 本站查看
    5. 齐赛卿,张亚伟,李君朝,申志国. 丹参多酚酸盐联合依达拉奉对急性脑梗死患者认知、脑动脉搏动指数及血清视锥蛋白样蛋白-1水平的影响. 实用临床医药杂志. 2023(22): 114-117+122 . 本站查看

    Other cited types(1)

Catalog

    Article views (315) PDF downloads (11) Cited by(6)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return